Relation between Ku80 and microRNA-99a expression and late rectal bleeding after radiotherapy for prostate cancer

Radiother Oncol. 2015 May;115(2):235-9. doi: 10.1016/j.radonc.2015.04.008. Epub 2015 Apr 30.

Abstract

Background and purpose: Late rectal bleeding is one of the severe adverse events after radiotherapy for prostate cancer. New biomarkers are needed to allow a personalized treatment.

Materials and methods: Four patients each with grade 0-1 or grade 2-3 rectal bleeding were randomly selected for miRNA array to examine miRNA expression in peripheral blood lymphocytes (PBLs). Based on results of miRNA array, 1 of 348 miRNAs was selected for microRNA assays. Then, expression of DNA-dependent protein kinase mRNA and miR-99a was analyzed in the PBLs of 97 patients. PBLs were exposed to 4Gy of X-ray ex-vivo.

Results: In the discovery cohort, grade 2-3 rectal bleeding was significantly higher in the Ku80 <1.09 expression group compared with ⩾1.09 group (P=0.011). In radiation-induced expression of miR-99a, grade 2-3 rectal bleeding was significantly higher in the miR-99a IR(+)/IR(-) >0.93 group compared with ⩽0.93 group (P=0.013). Most patients with grade 2-3 rectal bleeding were in the group with low Ku80 and high miR-99a expression. In the validation cohort, similar results were obtained.

Conclusion: A combination of low Ku80 expression and highly-induced miR-99a expression could be a promising marker for predicting rectal bleeding after radiotherapy.

Keywords: Late rectal toxicity; Micro RNA; Prostate cancer; RNA array; Radiotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antigens, Nuclear / genetics*
  • DNA-Binding Proteins / genetics*
  • Gastrointestinal Hemorrhage / etiology
  • Gastrointestinal Hemorrhage / genetics*
  • Gene Expression Regulation
  • Humans
  • Ku Autoantigen
  • Male
  • MicroRNAs / genetics*
  • Prostatic Neoplasms / radiotherapy*
  • Radiation Injuries / genetics*
  • Radiotherapy / adverse effects
  • Rectum / injuries*

Substances

  • Antigens, Nuclear
  • DNA-Binding Proteins
  • MIRN99 microRNA, human
  • MicroRNAs
  • Xrcc6 protein, human
  • Ku Autoantigen